send to a friend

From

To



Sent by a Friend: News from HarvardScience

Microchip-based device can detect rare tumor cells in bloodstream

May eventually help guide treatment planning, monitor respons

December 20, 2007

Sue McGreevey
Massachusetts General Hospital

A team of investigators from the Massachusetts General Hospital (MGH) BioMicroElectroMechanical Systems (BioMEMS) Resource Center and the MGH Cancer Center has developed a microchip-based device that can isolate, enumerate and analyze circulating tumor cells (CTCs) from a blood sample.

 
Circulating tumor cell (CTC) captured by post covered with antibody 'glue.'
foundations environments animal, vegetable, + mineral medicine + health culture + society engineering + technology